van der Heijde, D., Dijkmans, B., Schiff, M., Kivitz, A., de Vlam, K., Wordsworth, P., . . . Grp, A. (2008). Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS).
Citação do estilo Chicago (17ª ed.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.
Citação MLA (9ª ed.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.